MENU
VYNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
VYNE Therapeutics (VYNE) Ownership - Who owns VYNE Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.62M
P/E Ratio
0.78
Total Cash
70.19M
Projected Growth
N/A
Total Debt
123K
Revenue
493K
Risk (Beta)
2.47
Dividend Yield
N/A
Total Cash/Share
4.76
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
VYNE
Capitalization
37.6M
P/E Ratio
0.78
Risk (Beta)
2.47
Dividend Yield
N/A
Total Cash
70.2M
Total Cash/Share
4.76
Total Debt
123K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
493K
ROE
N/A
Book Value
63.5M
P/B Ratio
0.58
Cash Flow
N/A
Earnings
3.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
5.81
Current Revenue Per Employee
12100.00
Dividends Per Share - Security
N/A
EBITDA
-37.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.60
Revenue To Assets
-71.23
Shares Held By Institutions
16M
Shares Outstanding - Current
14.8M
Total Liabilities
12.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
7.296
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in development and commercialization of serlopitant products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
685 Route 202/206 North
Phone
+1 800 775-7936
Employees
10
Web
https://www.vynetherapeutics.com